高脂血症性重症急性胰腺炎的诊治进展

Progress on diagnosis and treatment of hyperlipidemic severe acute pancreatitis

高脂血症是临床上导致重症急性胰腺炎的病因之一,后者往往病情危重,病死率高,对患者生命造成较大的威胁。目前治疗上以个体化的综合治疗为主,迅速降低血脂,防治并发症的发生发展,以降低病死率。该文就高脂血症性重症急性胰腺炎的诊断与治疗进展作一综述。

Hyperlipidemia is one of the leading cause of severe acute pancreatitis （SAP）. Hyperlipidemic severe acute pancreatitis （HL-SAP） frequently shows a severe and life-threatening clinical condition, with high case fatality rate. The current therapy is mainly individualized by quickly lowering the level of blood lipids, prevention and treatment of HL-SAP relevant complications. All the effort is aim to decrease the case fatality rate of HL-SAP. This paper reviews the progress on diagnosis and treatment of HL-SAP.